Insider filing · LGND
Stephen L Sabba
Director
profile →
Ligand Pharmaceuticals Incorporated
LGND · Healthcare · 36 filings in 24 months
ticker →
Stephen L Sabba sold $545K of Ligand Pharmaceuticals Incorporated (LGND)
Executed Jun 16, disclosed Jun 18, 2 days later.
Value, as filed
$545K
2,145 sh × $254.00
Executed
Jun 16
the trade date, as filed
Disclosed
Jun 18
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SSStephen L Sabba (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $545K of LGND (2,145 sh × $254.00, as filed), executed Jun 16.
The name
LGNDHealthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Stephen L Sabba in LGND
LGNDSALE
Ligand Pharmaceuticals Incorporated
$208K1,000 sh × $207.87
Exec Mar 23
Filed Mar 25 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $410K
2,034 sh × $201.50
Exec Mar 3
Filed Mar 5 · 5:30 PM ET